» Articles » PMID: 34135312

Clobetasol Promotes Neuromuscular Plasticity in Mice After Motoneuronal Loss Via Sonic Hedgehog Signaling, Immunomodulation and Metabolic Rebalancing

Abstract

Motoneuronal loss is the main feature of amyotrophic lateral sclerosis, although pathogenesis is extremely complex involving both neural and muscle cells. In order to translationally engage the sonic hedgehog pathway, which is a promising target for neural regeneration, recent studies have reported on the neuroprotective effects of clobetasol, an FDA-approved glucocorticoid, able to activate this pathway via smoothened. Herein we sought to examine functional, cellular, and metabolic effects of clobetasol in a neurotoxic mouse model of spinal motoneuronal loss. We found that clobetasol reduces muscle denervation and motor impairments in part by restoring sonic hedgehog signaling and supporting spinal plasticity. These effects were coupled with reduced pro-inflammatory microglia and reactive astrogliosis, reduced muscle atrophy, and support of mitochondrial integrity and metabolism. Our results suggest that clobetasol stimulates a series of compensatory processes and therefore represents a translational approach for intractable denervating and neurodegenerative disorders.

Citing Articles

Physiopathological effects of entrance versus distal spread-out Bragg peak on mouse spinal cord neurons.

Torrisi F, Cammarata F, Bravata V, Calvaruso M, Alberghina C, Pavone A Sci Rep. 2025; 15(1):2134.

PMID: 39820768 PMC: 11739576. DOI: 10.1038/s41598-024-84902-2.


Sigma-1 receptor targeting inhibits connexin 43 based intercellular communication in chronic neuropathic pain.

Denaro S, DAprile S, Torrisi F, Zappala A, Marrazzo A, Al-Khrasani M Inflamm Res. 2024; 73(10):1711-1726.

PMID: 39095656 PMC: 11445328. DOI: 10.1007/s00011-024-01926-0.


Mitigating the Functional Deficit after Neurotoxic Motoneuronal Loss by an Inhibitor of Mitochondrial Fission.

Ciuro M, Sangiorgio M, Cacciato V, Cantone G, Fichera C, Salvatorelli L Int J Mol Sci. 2024; 25(13).

PMID: 39000168 PMC: 11241433. DOI: 10.3390/ijms25137059.


Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study.

Zhou X, Ling Y, Cui J, Wang X, Long N, Teng W Sci Rep. 2024; 14(1):12602.

PMID: 38824202 PMC: 11144219. DOI: 10.1038/s41598-024-63592-w.


Plectin plays a role in the migration and volume regulation of astrocytes: a potential biomarker of glioblastoma.

Zugec M, Furlani B, Castanon M, Rituper B, Fischer I, Broggi G J Biomed Sci. 2024; 31(1):14.

PMID: 38263015 PMC: 10807171. DOI: 10.1186/s12929-024-01002-z.


References
1.
Gulino R, Forte S, Parenti R, Gulisano M . TDP-43 as a Modulator of Synaptic Plasticity in a Mouse Model of Spinal Motoneuron Degeneration. CNS Neurol Disord Drug Targets. 2015; 14(1):55-60. DOI: 10.2174/1871527314666150116115414. View

2.
Valbuena G, Cantoni L, Tortarolo M, Bendotti C, Keun H . Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1 Amyotrophic Lateral Sclerosis. Front Neurosci. 2020; 13:1276. PMC: 6914819. DOI: 10.3389/fnins.2019.01276. View

3.
Albano R, Liu X, Lobner D . Regulation of system x(c)- in the SOD1-G93A mouse model of ALS. Exp Neurol. 2013; 250:69-73. DOI: 10.1016/j.expneurol.2013.09.008. View

4.
Bories C, Amendola J, Lamotte dIncamps B, Durand J . Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2007; 25(2):451-9. DOI: 10.1111/j.1460-9568.2007.05306.x. View

5.
Blasco H, Lanznaster D, Veyrat-Durebex C, Hergesheimer R, Vourch P, Maillot F . Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis. Expert Rev Neurother. 2020; 20(9):907-919. DOI: 10.1080/14737175.2020.1788389. View